07 Jan 2001

Remergil® 30 (Remergil® 30 mg/-45 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Remergil® 30 mg | -45 mg Filmtabletten; -6 mg | 2 ml | -15 mg | 5 ml Konzentrat

Depressive Erkrankungen.

Remergil® 30 Description, Presentation and Dosage

Remergil® 30 Description

Remergil® 30 Drug Class Description

Einzelstoffe

Remergil® 30 Drug Description

1 Filmtbl. enth.: Mirtazapin 30 mg/45 mg.

Remergil® 30 Generic Name

Remergil® 30 mg/-45 mg Filmtabletten

Remergil® 30 Presentation

Remergil® 30 Presentation

Remergil® 30 mg/-45 mg Filmtabletten; -6 mg/2 ml/-15 mg/5 ml Konzentrat

Remergil® 30 Manufacturer

Organon/Thiemann

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Remergil® 30 Dosage

Remergil® 30 Adult Dosage

Lactose 1H2O, Maisstärke, Hydroxypropylcellulose, Hochdisperses Siliciumdioxid, Magnesiumstearat, Poly(O-2-hydroxypropyl,O-methyl)cellulose, Macrogol 8000, Titandioxid E 171, -30 mg zusätzl.: Eisenoxidhydrat E 172, Eisen(III)-oxid (E 172).

Remergil® 30 Child Dosage


Remergil® 6 mg/2 ml/-15 mg/5 ml Konzentrat
Zus.: 1 Amp. (2 ml/5 ml) enth.: Mirtazapin 6 mg/15 mg.
Weit. Bestandteile: Methionin, Citronensäure 1H2O, Natriumchlorid, Natriumhydroxid od. Salzsäure zur Einstellung eines pH-Wertes von 4, Wasser f. Inj.-zwecke.

Remergil® 30 Precautions, Reactions and Contraindications

Remergil® 30 Special Precautions

Remergil® 30 Special Precautions

T 60 a

Remergil® 30 Adverse Reactions

Remergil® 30 Adverse Reactions

Strenge Ind.-Stellung Gr 4 .

Related Drugs - Psychiatry/Mental Health

Back to top